Massimo Framarini
Papers
1
Total Citations
33
H-Index
1
About
Massimo Framarini is a leading figure in minimally invasive surgical oncology, with a focused expertise in advanced splenic and hepatobiliary procedures. His major contribution lies in rigorously evaluating the comparative efficacy and safety of robotic versus laparoscopic techniques for complex operations, particularly splenectomy for splenomegaly. His landmark 2018 study, "Robotic vs laparoscopic splenectomy for splenomegaly," which has garnered 33 citations, provides critical evidence on the role of robotic assistance in managing enlarged spleens, a technically demanding surgical challenge. By systematically analyzing perioperative outcomes, Framarini has helped define best practices for minimally invasive approaches, demonstrating that robotic technology can offer distinct advantages in dexterity and visualization for these complex cases. His work directly informs surgical decision-making, balancing the benefits of advanced technology against traditional laparoscopy. Through this focused research, Framarini has established himself as a key voice in the evolution of robotic surgery, shaping how surgeons approach splenomegaly and contributing to the broader discourse on optimizing patient outcomes through technological innovation.
Research Focus
Key Achievements
Top Papers
- 1